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ABSTRACT
Background The joint associations of total and 
intensity- specific physical activity with obesity in relation 
to all- cause mortality risk are unclear.
Methods We included 34 492 adults (72% women, 
median age 62.1 years, 2034 deaths during follow- up) 
in a harmonised meta- analysis of eight population- based 
prospective cohort studies with mean follow- up ranging 
from 6.0 to 14.5 years. Standard body mass index 
categories were cross- classified with sample tertiles of 
device- measured total, light- to- vigorous and moderate- 
to- vigorous physical activity and sedentary time. In five 
cohorts with waist circumference available, high and 
low waist circumference was combined with tertiles of 
moderate- to- vigorous physical activity.
Results There was an inverse dose–response 
relationship between higher levels of total and intensity- 
specific physical activity and mortality risk in those who 
were normal weight and overweight. In individuals with 
obesity, the inverse dose–response relationship was only 
observed for total physical activity. Similarly, lower levels 
of sedentary time were associated with lower mortality 
risk in normal weight and overweight individuals but 
there was no association between sedentary time and 
risk of mortality in those who were obese. Compared 
with the obese- low total physical activity reference, the 
HRs were 0.59 (95% CI 0.44 to 0.79) for normal weight- 
high total activity and 0.67 (95% CI 0.48 to 0.94) for 
obese- high total activity. In contrast, normal weight- low 
total physical activity was associated with a higher risk 
of mortality compared with the obese- low total physical 
activity reference (1.28; 95% CI 0.99 to 1.67).
Conclusions Higher levels of physical activity were 
associated with lower risk of mortality irrespective of 
weight status. Compared with obesity- low physical 
activity, there was no survival benefit of being normal 
weight if physical activity levels were low.
INTRODUCTION
Low levels of physical activity and high preva-
lence of obesity are major public health challenges 
worldwide.1 2 Physical activity and weight status 
are connected entities through long- term energy 
balance. However, increased physical activity 
does not always lead to weight loss.3 4 Physical 
activity affects multiple metabolic pathways, such 
as glucose and lipid metabolism, and these path-
ways are considered strong mediators of adiposity- 
related morbidity.5 Thus, there is a strong biological 
plausibility that physical activity may counteract 
the detrimental consequences of obesity on 
longevity. Maintaining a healthy body weight, typi-
cally defined as a body mass index (BMI) between 
18.5 and 25 kg/m2, is considered a cornerstone in 
chronic disease prevention.6 However, the shape 
and magnitude of the dose–response association 
between BMI and risk of premature mortality is 
debated.7 8 Hence, to improve clinical counsel-
ling and public health messages, there is a need to 
understand the joint contributions of adiposity and 
other health behaviours, such as physical activity, in 
relation to mortality risk.
High levels of self- reported physical activity 
appear to attenuate, but not eliminate, the excess 
risk of mortality associated with obesity.9–11 
However, studies based on self- reported activity are 
prone to cognitive biases, often focus on leisure- 
time physical activity only and are unable to capture 
sporadic and light- intensity physical activity (LPA) 
that can be difficult to recall. In contrast, device- 
based measures of physical activity can capture the 
total volume of activity performed throughout the 
day as well as the full spectrum of physical activity 
intensity including sedentary time.
Using data from an international collaboration 
with device- measured and harmonised physical 
activity data, we examined the combined associa-
tions of total and intensity- specific physical activity 
and sedentary time with BMI in relation to risk of 
all- cause mortality. We also examined combined 
associations of moderate- to- vigorous physical 
activity (MVPA) and waist circumference with 




We have previously described how nine cohorts 
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through personal contacts.12–14 Study selection, data extraction 
and bias assessment have also been described in detail.12 For this 
study, we excluded one cohort restricted to individuals at high 
risk of type 2 diabetes because of the potential bias introduced by 
conditioning on a disease associated with both physical activity 
and BMI.15 Thus, data from the eight remaining cohorts from 
the USA, UK, Norway and Sweden were included in this pooled 
analysis.14 16–22 Since our previous work,13 we have acquired 
additional mortality follow- up from the Women’s Health Study 
(mean follow- up time: 6.3 years), the Framingham Heart Study 
(mean: 7.0 years), the REasons for Geographic And Racial 
Differences in Stroke (REGARDS, mean: 7.8 years) and the 
European Prospective Investigation into Cancer and Nutrition- 
Norfolk (mean: 6.7 years).
Harmonisation of physical activity data
Six studies used a version of the ActiGraph accelerometer14 17–20 22 
and two used an Actical accelerometer.16 21 Individual partici-
pant accelerometer data were reprocessed according to a stan-
dardised protocol by the participating study teams. We extracted 
data from only the vertical axis in 60 s epochs for harmonisa-
tion purposes. Non- wear time was defined as ≥90 consecutive 
minutes of zero counts, allowing for up to 2 min of non- zero 
counts if the interruption was preceded or followed by ≥30 
min of zero counts.23 We included all participants who recorded 
at least 10 hours of wear time per day for four or more days. 
Total physical activity was defined by total counts per day/wear 
time per day in minutes (counts per minute (CPM)). ActiGraph 
monitors defined LPA as 101–1951 CPM and MVPA as ≥1952 
CPM.24 Actical monitors defined LPA as 101–1534 CPM and 
MVPA as ≥1535 CPM.25 The sedentary time count threshold 
was 100 CPM for both monitors.26 27
Combinations of physical activity and weight status
We created tertiles of low, medium and high total physical activity, 
LPA, MVPA and sedentary time separately for each cohort and 
reported tertile medians for each cohort in online supplemental 
eTable 2. We combined these tertiles with the standard BMI cate-
gories (normal weight: 18.5–25, overweight: 25–30, obesity: 
≥30 kg/m2), yielding nine physical activity–BMI combinations 
for each physical activity exposure. LPA, MVPA and sedentary 
time were normalised by wear time (per cent of wear time) 
before creating the tertiles. BMI was based on height and weight 
measured by trained staff in five cohorts14 18 20 21 28 and self- 
reported in three cohorts.17 19 22 We had access to measured waist 
circumference as a measure of central obesity, defined as waist 
circumference ≥88 cm for women and ≥102 cm for men, in five 
cohorts.14 18 20 21 28 These two categories were combined with 
tertiles of MVPA yielding six combinations of physical activity 
and waist circumference.
Analysis
All cohorts restricted analysis to participants >40 years of age 
as in our earlier work.12 For this study, we excluded partici-
pants with less than 2 years of follow- up, a BMI less than 18.5 
kg/m2 or a history of cardiovascular disease (CVD) or cancer 
at the time of accelerometer assessment to minimise bias from 
reverse causation. In the REGARDS cohort, we were only able 
to exclude individuals with prevalent CVD because informa-
tion on prevalent cancers was not collected in the full cohort. 
For each cohort, we used Cox proportional hazards regression 
models to estimate the HRs with 95% CIs of all- cause mortality 
for the participants in eight combinations of BMI and physical 
activity, compared with the reference category (least active 
participants with obesity; ie, bottom third for physical activity 
or top third for sedentary time). Five HRs were estimated for 
waist circumference. The cohort- specific analyses were harmon-
ised according to various levels of adjustment. Our main model 
adjusted for age, sex (when applicable), socioeconomic status, 
smoking and the covariates included in each cohort’s published 
final multivariable- adjusted model (see online supplemental 
eTable 1 for details). Additionally, models with MVPA as the 
exposure were adjusted for sedentary time (continuous form), 
and models with LPA and sedentary time as exposure were 
adjusted for MVPA (continuous). We meta- analysed cohort- level 
HR estimates with a DerSimonian and Laird random effects 
model yielding eight pooled HRs with 95% CIs (five for waist 
circumference). When no cases were observed for a given combi-
nation of physical activity and BMI in a single cohort (eg, among 
never smokers in the cohorts including fewest participants), this 
cohort was not included in the meta- analysis of that particular 
combination (eg, obese with high physical activity) but was 
included in meta- analyses of the other combinations. The sample 
weights and the complex survey design of the National Health 
and Nutrition Examination Study (NHANES) were accounted 
for prior to analyses.20
Sensitivity analysis
We performed a sensitivity analysis among never smokers 
because multivariable adjustment for smoking status is unlikely 
to fully capture confounding from smoking behaviours on the 
BMI–mortality association.7 As smoking is strongly associated 
with morbidity this restriction may also reduce the risk of reverse 
causation bias from subclinical disease leading to low physical 
activity.29 Furthermore, we also present analyses including partic-
ipants reporting prevalent CVD or cancer at baseline, but with 
adjustment for these conditions in the statistical model.8 29–31 
Finally, we repeated the analysis only including the five cohorts 
with measured BMI and after exclusion of the REGARDS cohort 
that did not have information on prevalent cancers.
RESULTS
We included 34 492 participants (72% women; median age 
across cohorts: 62.1 years). These were followed for 6.0–14.5 
years (median 7.4 years), during which 2034 died (5.9%). Table 1 
presents the participant characteristics for each cohort with 
physical activity and sedentary time exposure levels in online 
supplemental eTable 2. Across cohorts, the prevalence of obesity 
ranged from 10.0% to 33.7% (median 19.4%). We present inde-
pendent, multivariable- adjusted associations between physical 
activity, sedentary time and BMI categories with mortality risk 
in table 2. Total physical activity showed the strongest magni-
tude of an inverse association with mortality, and this association 
was largely unaffected by restriction to never smokers. There 
was no association between high sedentary time and mortality 
risk when restricting the analysis to never smokers. Compared 
with being normal weight, overweight was associated with a 
lower mortality while the association was attenuated for obesity. 
Restricting to never smokers inverted the association for obesity 
although the CIs still overlapped the line of unity.
Joint associations of physical activity, sedentary time and 
adiposity with mortality
Higher total physical activity, LPA and MVPA were associated 
with lower risk of mortality in all BMI categories (figure 1). The 
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variables, but with more consistent dose–response patterns and 
stronger effect sizes for total physical activity. The effect sizes 
for high total physical activity versus obesity- low activity were 
similar across BMI categories: 0.59 (95% CI 0.44 to 0.79), 
0.56 (95% CI 0.40 to 0.79) and 0.67 (95% CI 0.48 to 0.94) for 
normal weight, overweight and obesity, respectively. In contrast, 
in individuals with obesity, high LPA was not associated with 
lower mortality (1.00, 95% CI 0.67 to 1.49) and the strength 
of the association for MVPA was weaker than observed in the 
normal weight and overweight categories. However, when BMI 
was replaced with waist circumference combined with MVPA, 
similar inverse associations of high MVPA were observed in 
those with low (0.56, 95% CI 0.36 to 0.97) and high (0.61, 
95% CI 0.46 to 0.82) central adiposity (figure 2). Less time 
spent sedentary appeared to be associated with lower mortality 
in the normal weight and overweight categories, but sedentary 
time was not associated with mortality risk in the obese category 
(figure 1).
Supplementary and sensitivity analyses
Sensitivity analysis restricting to never smokers removed the 
higher mortality risk among the normal weight- low active 
group but did not otherwise change interpretation of the results 
(figure 3). Results without adjustment for other physical activity 
behaviours are shown in online supplemental eFigure 1. Sensi-
tivity analyses excluding the REGARDS cohort and restricting 
to cohorts with measured BMI suggested results were largely 
Table 1 Descriptive characteristics of included cohorts















Age, mean (SD), years 54.9 (10.5) 55.4 (9.9) 52.6 (10.2) 52.5 (10.5) 68.2 (6.99) 69.0 (7.1) 78.2 (4.4)
Counts/min, mean (SD) 331 (131) 341 (147) 342 (216) 360 (295) 255 (107) 272 (129) 195 (108)
LPA/day, mean (SD), % of wear time 34.6 (8.0) 31.4 (8.3) 38.8 (9.3) 37.2 (9.8) 32.4 (7.6) 28.9 (7.5) 26.3 (8.2)
MVPA/day, mean (SD), % of wear time 3.9 (2.6) 4.3 (2.9) 3.4 (3.0) 3.9 (3.1) 3.6 (2.57) 4.4 (3.2) 2.0 (2.1)
Sedentary time/day, mean (SD), % of wear time 61.6 (8.7) 64.3 (9.0) 57.7 (10.2) 58.8 (11.0) 64.0 (8.7) 66.7 (8.9) 71.8 (9.1)
BMI, mean (SD), kg/m2 25.2 (4.2) 26.4 (3.4) 25.4 (3.8) 25.8 (2.9) 26.4 (4.25) 26.9 (3.6) 27.1 (3.7)
Waist circumference, mean (SD), cm ni ni ni ni 89.1 (11.09) 99.8 (10.0) 99.8 (10.7)
BMI ≥30 kg/m2, n (%) 122 (11.6) 111 (12.7) 50 (11.6) 27 (8.0) 476 (17.9) 337 (16.8) 178 (18.9)
Smoking, n (%)
  Never 483 (46.0) 400 (45.7) 177 (40.9) 147 (43.6) 1581 (59.5) 879 (43.8) 413 (43.9)
  Former 361 (34.4) 342 (39.1) 133 (30.7) 122 (36.2) 919 (34.6) 1016 (50.6) 489 (52.0)
  Current 206 (19.6) 133 (15.2) 123 (28.4) 68 (20.2) 158 (5.9) 114 (5.7) 38 (4.0)
Ethnicity, n (%)*
  White ni ni ni ni 2644 (99.8) 1992 (99.5) 916 (99.5)
  Black ni ni ni ni 0 (0.0) 2 (0.1) 1 (0.1)
  Other ni ni ni ni 5 (0.2) 8 (0.4) 4 (0.4)
  
  













Age, mean (SD), years 56.2 (11.3) 55.5 (10.7) 67.8 (8.6) 69.3 (8.3) 55.5 (11.0) 53.4 (10.1) 71.7 (5.5)
Counts/min, mean (SD) 151 (124) 167 (118) 86 (64.3) 109 (80) 280 (121) 343 (153) 225 (103)
LPA/day, mean (SD), % of wear time 21.1 (6.7) 21.8 (7.5) 16.8 (7.6) 17.9 (7.7) 40.4 (9.9) 39.5 (11.1) 32.2 (8.4)
MVPA/day, mean (SD), % of wear time 1.9 (2.3) 2.2 (2.3) 0.8 (1.3) 1.2 (1.8) 2.1 (2.1) 3.5 (2.9) 1.7 (1.9)
Sedentary time/day, mean (SD), % of wear time 77.1 (7.5) 76.1 (8.2) 82.4 (8.1) 80.9 (8.4) 57.5 (10.6) 57.0 (12.1) 66.1 (9.1)
BMI, mean (SD), kg/m2 27.4 (5.8) 28.9 (4.7) 29.0 (6.3) 28.3 (4.7) 28.9 (6.8) 28.7 (4.9) 26.4 (4.9)
Waist circumference, mean (SD), cm 94.5 (14.5) 103.0 (12.3) 89.5 (14.9) 98.4 (12.0) 95.3 (14.7) 103.1 (12.9) ni
BMI ≥30 kg/m2, n (%) 426 (26.2) 460 (33.3) 1350 (37.0) 787 (28.8) 500 (34.4) 455 (33.0) 2775 (19.9)
Smoking, n (%)
  Never 862 (52.9) 782 (56.6) 2098 (57.5) 1150 (42.1) 847 (58.3) 575 (41.7) 7112 (50.9)
  Former 641 (39.4) 506 (36.6) 1179 (32.3) 1303 (47.7) 371 (25.5) 476 (34.5) 6379 (45.7)
  Current 125 (7.7) 93 (6.7) 372 (10.2) 281 (10.3) 235 (16.2) 328 (23.8) 477 (3.4)
Ethnicity, n (%)
  White 1461 (89.7) 1261 (91.3) 2354 (64.5) 1987 (72.7) 1101 (75.8) 1070 (77.6) 13 290 (95.2)
  Black 52 (3.2) 24 (1.7) 1295 (35.5) 745 (27.3) 148 (10.2) 127 (9.2) 224 (1.6)
  Other 115 (7.1) 96 (7.0) 0 (0.0) 0 (0.0) 203 (14.0) 182 (13.2) 454 (3.2)
All studies used a version of the ActiGraph accelerometers, except REGARDS and FHS which used Actical accelerometers.
*Numbers may not sum to total sample due to missing data.
ABC, Sweden Attitude, Behaviour and Change study; BMI, body mass index; BRHS, British Regional Heart Study; EPIC- Norfolk, European Prospective Investigation into Cancer 
and Nutrition- Norfolk; FHS, Framingham Heart Study; LPA, light- intensity physical activity; MVPA, moderate- to- vigorous physical activity; NHANES, National Health and Nutrition 
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robust (online supplemental eFigures 2 and 3). In individuals 
with obesity, the effect size for high total activity was attenu-
ated (HR 0.87, 95% CI 0.57 to 1.33) while the effect size for 
high MVPA was accentuated (HR 0.69, 95% CI 0.50 to 0.95). 
Analysis including individuals with prevalent CVD or cancer, but 
with adjustment for these variables, showed a similar pattern as 
the main analysis, but with slightly stronger effect sizes (online 
supplemental eFigure 4), with descriptive characteristics for 
these participants in online supplemental eTable 3.
DISCUSSION
In this harmonised meta- analysis of almost 35 000 participants 
with device- measured physical activity, we observed an inverse 
dose–response relationship between higher levels of total and 
intensity- specific physical activity and mortality within the 
normal weight (BMI 18.5–25) and overweight categories (BMI 
25–30). An inverse dose–response relationship within the 
obese category (BMI >30) was only observed for total physical 
activity. However, the inverse association between MVPA and 
mortality risk was similar in low and high waist circumference 
categories, suggesting a role of MVPA in determining central 
adiposity- related mortality. Low sedentary time was associated 
with lower mortality risk in those with normal weight and over-
weight, but not in individuals with obesity. A consistent finding 
was that being normal weight did not provide any survival bene-
fits in those with low physical activity or high sedentary time, 
compared with the obese- low active (or high sedentary time) 
referent. These results support the main 2020 WHO physical 
activity and sedentary behaviour recommendations that all 
adults should undertake regular physical activity and ‘every 
move counts’.32
A dose–response relationship between MVPA and risk of 
premature mortality within the normal weight and overweight 
categories largely corroborates earlier studies based on self- 
reported activity.9–11 33 34 Some of these studies10 11 also reported 
dose–response relationships for physical activity among individ-
uals with obesity, while some did not.9 34 While these stratified 
analyses provide useful insights into physical activity prescrip-
tion in population subgroups (ie, does physical activity promote 
longevity in those with or without obesity), they do not address 
the possibility that risk of poor health outcomes may be shaped by 
the combined exposure to both obesity and physical activity. Nor 
do they provide insight on whether physical activity may in fact 
eliminate the higher mortality risk observed with obesity.7 Studies 
examining the joint association of self- reported physical activity 
and adiposity have generally reported that physical activity atten-
uated, but did not eliminate, the increased mortality risk among 
individuals with obesity.9–11 For example, in the Nurses’ Health 
Study, all- cause mortality risk was about 2.5 times higher among 
women with obesity with less than 1 hour of exercise per week 
that was attenuated to an HR of 1.9 among women reporting 
more than 3.5 hours of exercise per week, as compared with the 
healthy BMI- most active reference group.10 Similarly, in a recent 
study including about 300 000 individuals from the UK Biobank 
cohort, also using the healthy BMI- most active as the reference, 
the all- cause mortality HR among those with obesity type I (BMI 
30–35) was 1.4 for the least active and 1.2 for the most active 
category.9 In this study, the most active third of total activity 
had an approximate 30%–40% lower risk compared with the 
obese- least active reference, irrespective of their BMI. Our find-
ings are therefore in agreement with earlier studies based on self- 
reported MVPA, and we extend these observations by showing 
Table 2 Independent associations between physical activity, sedentary time and BMI with all- cause mortality
Multivariable adjusted Multivariable adjusted, restricted to never smokers
n (deaths) HR (95% CI) n (deaths) HR (95% CI)
BMI categories
  Normal weight (18.5–25 kg/m2) 13 030 (745) Reference 6823 (318) Reference
  Overweight (25–30 kg/m2) 13 400 (784) 0.85 (0.75 to 0.97) 6548 (315) 0.91 (0.76 to 1.08)
  Obesity (≥30 kg/m2) 8062 (505) 0.93 (0.82 to 1.07) 4114 (231) 1.12 (0.91 to 1.37)
Total physical activity
  T1 (least active) 11 474 (1230) Reference 5603 (508) Reference
  T2 11 511 (475) 0.59 (0.52 to 0.67) 5839 (203) 0.66 (0.51 to 0.87)
  T3 11 507 (329) 0.53 (0.42 to 0.66) 6043 (153) 0.59 (0.47 to 0.73)
Light physical activity
  T1 (least active) 11 483 (1112) Reference 5760 (470) Reference
  T2 11 500 (531) 0.69 (0.62 to 0.77) 5830 (224) 0.74 (0.62 to 0.88)
  T3 11 509 (391) 0.66 (0.54 to 0.82) 5895 (170) 0.70 (0.56 to 0.86)
Moderate- to- vigorous physical activity
  T1 (least active) 11 481 (1206) Reference 5527 (491) Reference
  T2 11 502 (486) 0.66 (0.58 to 0.74) 5848 (214) 0.73 (0.59 to 0.91)
  T3 11 509 (342) 0.61 (0.47 to 0.80) 6110 (159) 0.66 (0.52 to 0.83)
Sedentary time
  T1 (least sedentary) 11 495 (356) Reference 5913 (154) Reference
  T2 11 505 (535) 0.94 (0.71 to 1.26) 5839 (238) 0.97 (0.67 to 1.40)
  T3 11 492 (1143) 1.31 (0.87 to 1.96) 5733 (472) 1.07 (0.82 to 1.40)
n=34 492, deaths=2034 in multivariable- adjusted model, n=17 485, deaths=886 in multivariable- adjusted model restricted to never smokers. Analyses are restricted to 
individuals with >2 years of follow- up and excluding individuals with prevalent cardiovascular disease (CVD) or cancer at baseline. Multivariable adjustment includes age, sex 
(when applicable), socioeconomic status, smoking and the covariates included in each study’s published final multivariable- adjusted model (see online supplemental eTable 1 for 
details). Moderate- to- vigorous physical activity is adjusted for sedentary time, light physical activity and sedentary time are adjusted for moderate- to- vigorous physical activity. 
Physical activity and sedentary time are further adjusted for BMI (continuous form) and BMI is adjusted for moderate- to- vigorous physical activity.
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that device- measured physical activity, irrespective of intensity, 
may outweigh the risk of premature mortality from obesity. We 
show that an overall volume of physical activity comparable 
with the most active third of our samples was associated with a 
pronounced lower mortality risk among individuals with obesity, 
and that even reaching a physical activity level corresponding 
to the second tertile may provide the majority of the survival 
benefit. In the nationally representative US NHANES and the 
Norwegian National Physical Activity Survey cohorts, the differ-
ence in non- sedentary time (LPA +MVPA, assuming 16 hours of 
daily awake time) between the least active and the middle third 
of total physical activity was between 1 and 1.5 hours/day in all 
BMI categories. In comparison, the difference between the least 
active and the middle active third of MVPA was roughly 12 min/
day in the NHANES and 20 min/day in the Norwegian National 
Physical Activity Survey. MVPA requires an intensity equivalent 
to at least brisk walking and may be achieved by active trans-
portation, walking, exercise and heavy gardening activities. In 
contrast, examples of LPA include casual walking, household 
chores, yoga or tai chi, and pétanque. Thus, physical activity 
can be accumulated by combining LPA and MVPA differently to 
promote longevity.32
The dose–response pattern between higher BMI and mortality 
is not linear, but has a curvilinear slope at a BMI above 30 kg/
m2.7 The cohorts included in our study were not large enough 
to permit a more granular assessment of the joint associations 
at higher levels of BMI which may explain why we did not 
observe increased mortality with obesity in our sample. Further, 
particularly the normal weight category may be susceptible to 
residual confounding from disease.29 This would also attenuate 
the obesity–mortality association compared with normal weight 
and thereby impact the joint association pattern. The higher 
mortality risk with normal weight- low activity provides some 
evidence in this direction. When we restricted our analysis to 
never smokers this higher mortality was no longer evident, but 
the rest of the association pattern was robust. Yet, inference 
from conservative analysis of observational data and Mende-
lian randomisation studies suggest that a BMI below 20 may 
be causally associated with higher mortality risk.7 35 We there-
fore suggest that further studies on this topic perform a detailed 
assessment at both high (eg, >35 km/m2) and low levels of BMI 
when possible. We included population- based cohorts three of 
which used using national sampling frames but our combined 
data set is selected towards women and older individuals. This 
could have introduced selection of individuals with healthy 
ageing and may impact the generalisability of the observed joint 
association pattern to younger adults as the obesity–mortality 
association weakens with advancing age.7 36
We extend previous work in this data set12 by showing the 
importance of the total volume of physical activity across stan-
dard categories of BMI. It is unclear why high LPA and MVPA 
among individuals with obesity were not associated with lower 
mortality risk when there was clear evidence of an association 
in the middle tertiles. This may reflect statistical uncertainty as 
individuals with obesity and high MVPA constituted the smallest 
proportion of the sample. Alternatively, misclassification of 
activity intensities could be more pronounced with obesity as 
the absolute accelerometer intensity thresholds do not account 
for individual variation in fitness. Further, the biomechan-
ical properties of walking are affected by obesity37 which may 
Figure 1 Joint associations of physical activity or sedentary time and body mass index (BMI) with risk of all- cause mortality. n=34 492, 
deaths=2034. Individuals self- reporting prevalent cardiovascular disease (CVD) or cancer are excluded. Analysis of sedentary time includes n=33 552; 
1920 deaths as there were no cases in the reference category in the British Regional Heart Study. Models are adjusted for age, sex (when applicable), 
socioeconomic status, smoking and the covariates included in each study’s published final multivariable- adjusted model (see online supplemental 
eTable 1 for details). Additionally, models using moderate- to- vigorous physical activity were adjusted for sedentary time (continuous form) with 
sedentary time and light physical activity adjusted for moderate- to- vigorous physical activity (continuous). Median activity and sedentary time in 
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also result in misclassification of LPA and MVPA. In contrast, 
total physical activity is cut- point invariant. A recent analysis 
of physical activity measured by wrist- worn accelerometry in 
almost 100 000 participants corroborates the importance of the 
total volume of activity for lowering mortality but also suggests 
additional benefits are accrued if the total volume is accumu-
lated through higher intensity activity.38 Importantly, high waist 
circumference was not associated with higher mortality risk in 
those with medium or high MVPA. As centrally distributed fat is 
considered more detrimental than subcutaneous fat,39 engaging 
in MVPA may be particularly relevant for those with central 
obesity. The association between sedentary time and mortality 
differed from that reported in our earlier work.12 Possible expla-
nations include the current use of tertiles instead of quartiles, or 
additional follow- up time in some of the included cohorts.31 40 
Sedentary time was defined as absence of movement from waist- 
mounted or hip- mounted accelerometry and may also include 
time standing completely still.41 Standing may account for a 
large part of non- movement but would probably decrease with 
age and retirement from work.42 Hence, differences in partici-
pant demographics would influence the extent of misclassifica-
tion in each cohort.
We highlight two implications of our findings for public 
health. First, physical activity should be promoted regardless of 
the weight status of individuals. Healthcare providers may be 
less inclined to discuss lifestyle factors such as physical activity 
and diet with individuals who have a healthy body weight.43–45 
Our results and the work of others suggest substantial benefits 
may accrue if physical activity levels are increased in this popu-
lation.9 10 34 46 Second, very few people with obesity succeed in 
achieving a sustained weight loss47 despite this being an integral 
part of primary care management of obesity.48 This is because 
body weight is determined by a complex relationship between 
multiple behavioural, environmental and genetic factors.49 
Focusing communication on the positive benefits of regular 
physical activity in this population, such as improved mental 
health,32 improved physical functioning,32 decreased reliance on 
medications to control cardiometabolic risk markers45 and lower 
mortality risk, irrespective of any concurrent weight loss, may 
help send a more positive message.
Our findings should be interpreted in the light of several 
limitations. BMI is not a direct measure of body fat and may 
misclassify individuals with high lean mass into the overweight 
or obese categories. This bias could potentially inflate estimates 
of the benefits of higher activity in these categories. We used 
sample- specific tertiles to categorise physical activity variables. 
The largest mortality benefits are observed with small differences 
at the lower end of the activity spectrum,32 and these nuances 
may not be fully captured with tertiles. We excluded individuals 
with prevalent CVD or cancer as well as deaths within the first 
Figure 2 Joint associations of moderate- to- vigorous physical activity (MVPA) and waist circumference with risk of all- cause mortality. Top panel: 
excluding individuals with self- reporting prevalent cardiovascular disease (CVD) or cancer (n=17 773; 1443 deaths). Bottom panel: as top panel but 
further restricted to never smokers (n=9136; 608 deaths). Both models are adjusted for age, sex (when applicable), socioeconomic status, smoking 
(top panel only), sedentary time (continuous) and the covariates included in each study’s published final multivariable- adjusted model (see online 
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2 years of follow- up to reduce the risk of prevalent or subclin-
ical conditions being a cause of lower activity and/or adiposity 
which would bias our results. However, it is possible that this 
time frame is insufficient to fully remove this bias7 31 and we 
were not able to exclude individuals with prevalent cancer in the 
REGARDS cohort as these data were not collected. Our analysis 
is based on the constant exposure assumption as we were unable 
to account for changes in physical activity or BMI over time. 
Careful modelling of changes in exposure over time in relation 
to later health outcomes should be a priority in future studies.50 
We included cohorts from high- income western countries with 
distinct physical activity patterns and a high prevalence of 
obesity which may limit generalisability of the results to low and 
middle- income countries. Finally, as a meta- analysis of observa-
tional studies, residual biases from selection, measurement error 
or confounding cannot be refuted.
In summary, higher physical activity was associated with lower 
risk of mortality irrespective of weight status. Compared with 
obesity- low physical activity, there was no survival benefit of 
being normal weight if physical activity levels were low. Clini-
cians, communities and public health specialists should promote 
physical activity for longevity irrespective of weight status.
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eTable 2. Physical activity (medians (interquartile range)) levels across combinations of physical activity and BMI 
 NNPAS ABC 
EPIC-
NORFOLK 
BRHS FHS REGARDS NHANES WHS 
Median of 
medians* 
Total Physical Activity (CPM)          
Normal weight – low total activity 217 (86) 219 (73) 158 (62) 95 (46) 80 (29) 36 (23) 180 (66) 124 (49) 169 
Normal weight – medium total activity 321 (47) 318 (49) 247 (46) 179 (49) 135 (27) 78 (25) 272 (54) 210 (41) 260 
Normal weight – high total activity 457 (130) 493 (135) 367 (114) 322 (134) 239 (115) 157 (83) 442 (155) 345 (101)  405 
Overweight – low total activity 214 (70) 220 (78) 156 (56) 94 (46) 79 (37) 38 (20) 173 (61) 126 (47) 165 
Overweight – medium total activity 310 (49) 314 (51) 243 (43) 175 (42) 134 (30)  78 (24) 274 (47) 209 (40) 259 
Overweight – high total activity 445 (111) 438 (129) 361 (103) 290 (101) 222 (87) 152 (68) 430 (134) 338 (92) 396 
Obese – low total activity 198 (80) 185 (78) 145 (60) 90 (46) 77 (35) 37 (20) 174 (60) 123 (48) 160 
Obese – medium total activity 317 (62) 312 (34) 241 (43) 177 (46) 135 (29) 76 (24) 271 (49) 209 (43) 256 
Obese – high total activity 435 (105) 431 (85) 350 (99) 258 (61) 211 (66) 141 (60) 394 (100) 321 (73) 372 
Light Physical Activity (%/day)          
Normal weight – low LPA 25.5 (5.0) 29.0 (5.6) 24.0 (4.9) 18.0 (3.7) 15.1 (3.7) 9.8 (5.2) 30.1 (6.2) 23.4 (5.3) 24.8 
Normal weight – medium LPA 32.2 (3.3) 38.0 (4.7) 30.6 (3.2) 26.0 (3.4) 20.6 (3.0) 16.6 (3.1) 40.2 (5.4) 31.9 (3.4) 32.0 
Normal weight – high LPA 41.6 (6.0) 47.8 (6.8) 38.5 (5.8) 34.0 (6.7) 27.8 (5.9) 24.8 (6.4) 49.8 (8.0) 41.6 (6.4) 41.6 
Overweight – low LPA 24.9 (5.5) 29.9 (6.4) 23.7 (5.0) 19.0 (4.2) 14.8 (4.0) 9.9 (4.5) 29.2 (7.1) 23.4 (5.4) 24.3 
Overweight – medium LPA 32.5 (3.5) 37.9 (4.9) 30.6 (3.1) 25.9 (3.4) 20.7 (3.0) 16.9 (3.3) 39.5 (4.8) 31.8 (3.6) 32.2 
Overweight – high LPA 41.6 (6.3) 48.0 (5.6) 38.1 (5.8) 34.0 (5.8) 28.2 (6.4) 24.6 (6.0) 50.5 (7.2) 41.5 (6.2) 41.6 
Obese – low LPA 24.6 (7.0) 28.9 (8.3) 22.4 (5.8) 18.6 (5.4) 14.6 (4.1) 9.9 (4.9) 29.7 (7.1) 22.6 (6.2) 23.6 
Obese – medium LPA 32.3 (3.2) 38.7 (3.0) 30.5 (2.9) 25.4 (3.3) 20.8 (2.7) 16.5 (3.0) 39.7 (4.3) 31.8 (3.4) 32.1 
Obese – high LPA 40.7 (5.7) 46.9 (4.7) 38.4 (6.1) 32.7 (5.1) 28.3 (5.6) 24.6 (6.1) 50.0 (7.9) 41.0 (5.4) 40.9 
Moderate-to-Vigorous Physical 
Activity (%/day) 
         
Normal weight – low MVPA 1.54 (1.32) 1.49 (1.06) 1.41 (1.08) 0.22 (0.27) 0.4 (0.4) 0.01 (0.04) 0.44 (0.44) 0.23 (0.24) 0.42 
Normal weight – medium MVPA 3.56 (1.02) 2.98 (1.14) 3.41 (1.13) 1.38 (0.71) 1.5 (0.8) 0.34 (0.35) 1.75 (0.98) 1.12 (0.65) 1.63 
Normal weight – high MVPA 6.67 (2.56) 6.17 (2.87) 6.59 (2.79) 4.32 (2.55) 3.7 (2.3) 2.12 (2.13) 4.72 (2.99) 3.89 (2.17) 4.52 
Overweight – low MVPA 1.74 (1.17) 1.18 (1.09) 1.35 (1.05) 0.20 (0.27) 0.3 (0.5) 0.00 (0.04) 0.41 (0.41) 0.23 (0.23) 0.41 
Overweight – medium MVPA 3.56 (0.90) 3.04 (1.01) 3.37 (1.11) 1.27 (0.76) 1.4 (0.7) 0.31 (0.33) 1.76 (0.87) 1.09 (0.62) 1.58 
Overweight – high MVPA 6.34 (2.47) 5.75 (2.31) 6.38 (2.78) 3.67 (2.31) 3.5 (2.0) 2.00 (1.92) 4.55 (2.99) 3.64 (1.92) 4.11 
Obese – low MVPA 1.18 (1.32) 0.71 (1.05) 1.14 (1.10) 0.13 (0.29) 0.4 (0.5) 0.00 (0.03) 0.49 (0.46) 0.24 (0.22) 0.49 
Obese – medium MVPA 3.31 (1.09) 2.66 (0.83) 3.20 (1.14) 1.39 (0.82) 1.4 (0.7) 0.27 (0.31) 1.75 (0.97) 1.02 (0.61) 1.58 
Obese – high MVPA 5.49 (2.45) 5.64 (2.11) 6.07 (2.58) 3.47 (1.43) 3.3 (1.5) 1.71 (1.61) 4.03 (1.87) 3.34 (1.59) 3.75 
Sedentary time (%/day)          
Normal weight – low sedentary 53.7 (6.4) 47.9 (7.1) 56.7 (6.7) 62.5 (6.3) 69.1 (6.9) 73.5 (7.2) 45.5 (8.9) 55.9 (7.2) 54.8 
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Normal weight – medium sedentary 63.5 (3.3) 58.5 (4.4) 65.2 (3.6) 72.0 (3.9) 77.2 (2.9) 82.3 (3.6) 58.1 (5.4) 66.4 (3.7) 64.4 
Normal weight – high sedentary 70.7 (5.6) 67.9 (5.5) 72.8 (5.6) 80.5 (5.2) 83.2 (4.1) 90 (5.4) 68.1 (6.2) 75.6 (5.8) 71.8 
Overweight – low sedentary 53.9 (6.8) 48.3 (6.5) 56.8 (6.8) 63.1 (6.5) 69.3 (6.7) 74.1 (6.4) 46.0 (8.1) 56.1 (6.6) 55.0 
Overweight – medium sedentary 63.4 (3.6) 58.7 (4.4) 65.6 (3.6) 72.1 (4.1) 77.3 (3.0) 82.3 (3.3) 58.3 (4.8) 66.4 (3.9) 64.5 
Overweight – high sedentary 71.3 (6.0) 66.7 (7.6) 73.5 (5.7) 80.8 (4.3) 83.7 (4.5) 89.8 (4.8) 68.8 (7.7) 75.6 (5.9) 72.4 
Obese – low sedentary 55.1 (6.2) 48.9 (6.3) 57.0 (6.4) 64.9 (4.2) 69.5 (5.7) 73.9 (6.3) 46.6 (9.4) 57.1 (5.4) 56.1 
Obese – medium sedentary 62.7 (4.2) 57.7 (4.0) 65.6 (3.5) 74.0 (3.9) 77.4 (3.0) 82.6 (3.5) 58.6 (5.1) 66.7 (3.6) 64.2 
Obese – high sedentary 72.2 (87.1) 69.5 (10.9) 74.7 (6.7) 80.3 (5.7) 84.5 (4.8) 89.9 (5.1) 68.5 (7.4) 76.5 (6.4) 73.5 
Participants without cardiovascular disease and cancer at baseline (in REGARDS, participants are only free from cardiovascular disease). REGARDS; REasons for Geographical and Racial 
differences in Stroke, ABC; Sweden Attitude, Behaviour and Change study, BRHS; British Regional Heart Study, WHS; Women’s Health Study, FHS; Framingham Heart Study, NHANES; National 
Health and Nutrition Examination Study, NNPAS; Norwegian National Physical Activity Survey, EPIC-Norfolk; The European Prospective Investigation into Cancer and Nutrition – Norfolk. *CPM, 
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eFigure 1. Joint associations of physical activity or sedentary time and BMI with risk of all-cause mortality without control 
for other physical activity intensities  
 
N = 34,492, deaths = 2034. Models are adjusted for age, sex (when applicable), socioeconomic status, smoking, and the covariates included in each study’s published final multivariable-adjusted model (see eTable 1 
for details).  
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eFigure 2. Joint associations of physical activity or sedentary time and BMI with risk of all-cause mortality, excluding the 
REGARDS cohort  
 
N = 28,111, deaths = 1333. Individuals self-reporting prevalent CVD or cancer are excluded. Analysis of sedentary time includes n = 27,171, 1219 deaths as there were no cases in the reference 
category in the British Regional Heart Study. Models are adjusted for age, sex (when applicable), socioeconomic status, smoking, and the covariates included in each study’s published final 
multivariable-adjusted model (see eTable 1 for details). Additionally, models using moderate-to-vigorous physical activity were adjusted for sedentary time (continuous form) with sedentary time and 
light physical activity adjusted for moderate-to-vigorous physical activity (continuous). 
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eFigure 3. Joint associations of physical activity or sedentary time and BMI with risk of all-cause mortality, cohorts with 
measured BMI  
 
N = 17,829, deaths = 1463. Individuals self-reporting prevalent CVD or cancer are excluded. Analysis of sedentary time includes n = 16,889, 1349 deaths as there were no cases in the reference 
category in the British Regional Heart Study. Models are adjusted for age, sex (when applicable), socioeconomic status, smoking, and the covariates included in each study’s published final 
multivariable-adjusted model (see eTable 1 for details). Additionally, models using moderate-to-vigorous physical activity were adjusted for sedentary time (continuous form) with sedentary time and 
light physical activity adjusted for moderate-to-vigorous physical activity (continuous). 
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eFigure 4. Joint associations between physical activity or sedentary time and BMI with risk of all-cause mortality, 
including individuals with self-reported prevalent CVD or cancer at start of follow-up 
 
N = 42,957, deaths = 3338. Models are adjusted for age, sex (when applicable), socioeconomic status, smoking, CVD, cancer, and the covariates included in each study’s published final 
multivariable-adjusted model (see eTable 1 for details). Additionally, models using moderate-to-vigorous physical activity were adjusted for sedentary time (continuous form) with sedentary time and 
light physical activity adjusted for moderate-to-vigorous physical activity (continuous). 
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eTable 3. Descriptive characteristics of cohorts, including participants with self-reported prevalent CVD or cancer 















Age, mean (SD), years 55.7 (11.0) 57.1 (10.7) 52.6 (10.2) 53.1 (10.5) 69.7 (7.5) 70.9 (7.5) 78.2 (4.5) 
Counts/min, mean (SD) 325 (133) 331 (150) 341 (213) 358 (289) 237 (107) 249 (127) 190 (110) 
LPA/day, mean (SD), % of wear-time 34.3 (8.1) 30.9 (8.4) 38.8 (9.4) 37.2 (9.9) 31.5 (8.0) 27.9 (7.7) 25.9 (8.2) 
MVPA/day, mean (SD), % of wear-time 3.8 (2.6) 4.2 (2.9) 3.4 (3.0) 4.0 (3.2) 3.2 (2.5) 3.9 (3.1) 1.9 (2.1) 
Sedentary time/day, mean (SD), % of wear-time 61.9 (8.8) 65.0 (9.2) 57.8 (10.2) 58.8 (11.2) 65.3 (9.1) 68.2 (9.1) 72.3 (9.1) 
BMI, mean (SD), kg/m2 25.3 (4.2) 26.4 (3.4) 25.4 (3.8) 25.9 (3.0) 26.8 (4.6) 27.2 (3.7) 27.2 (3.8) 
Waist circumference, mean (SD), cm ni ni ni ni 90.3 (11.8) 100.9 (10.2) 100.0 (10.8) 
BMI ≥30 kg/m2, No. (%) 138 (11.8) 138 (13.2) 56 (12.3) 32 (8.6) 832 (20.1) 637 (18.9) 260 (19.8) 
Smoking, No. (%)         
  Never 534 (45.8) 456 (43.5) 186 (40.8) 160 (43.0) 2455 (59.4) 1402 (41.7) 569 (43.4) 
  Former 400 (34.3) 430 (41.0) 140 (30.7) 137 (36.8) 1424 (34.4) 1776 (52.8) 695 (53.0) 
  Current 233 (20.0) 162 (15.5) 130 (28.5) 75 (20.3) 257 (6.2) 185 (5.5) 47 (3.6) 
Ethnicity, No. (%)*        
  White ni ni ni ni 4115 (99.8) 3338 (99.5) 1276 (99.5) 
  Black ni ni ni ni 1 (0.0) 3 (0.1) 1 (0.1) 
  Other ni ni ni ni 6 (0.1) 13 (0.4) 5 (0.4) 
Prevalent CVD, No. (%) 54 (4.6) 117 (11.2) 6 (1.3) 22 (6.0) 972 (23.5) 1137 (33.8) 207 (15.8) 
Prevalent Cancer, No. (%) 74 (6.3) 67 (6.4) 13 (2.9) 82 (2.2) 729 (17.6) 451 (13.4) 197 (15.0) 
        
















Age, mean (SD), years 58.1 (11.9) 58.2 (12.0) 68.2 (8.7) 69.8 (8.4) 57.2 (11.7) 55.8 (11.6) 71.9 (5.6) 
Counts/min, mean (SD) 143 (117) 160 (131) 84 (64) 105 (79) 268 (120) 322 (157) 222 (103) 
LPA/day, mean (SD), % of wear-time 20.6 (6.8) 21.3 (7.7) 16.6 (7.6) 17.6 (7.7) 39.6 (10.0) 38.3 (11.3) 32.0 (8.4) 
MVPA/day, mean (SD), % of wear-time 1.8 (2.2) 2.1 (2.4) 0.8 (1.3) 1.2 (1.7) 1.9 (2.0) 3.1 (2.9) 1.7 (1.8) 
Sedentary time/day, mean (SD), % of wear-time 77.7 (7.6) 76.7 (8.5) 82.6 (8.1) 81.3 (8.4) 58.5 (10.8) 58.5 (12.5) 66.3 (9.1) 
BMJ Publishing Group Limited (BMJ) disclaims all liability and responsibility arising from any reliance
Supplemental material placed on this supplemental material which has been supplied by the author(s) Br J Sports Med
 doi: 10.1136/bjsports-2021-104827–9.:10 2021;Br J Sports Med, et al. Tarp J
11 
 
BMI, mean (SD), kg/m2 27.6 (5.7) 28.9 (4.7) 29.0 (6.2) 28.3 (4.6) 28.9 (6.6) 28.7 (4.9) 26.4 (4.9) 
Waist circumference, mean (SD), cm 95.3 (14.5) 103.5 (12.2) 89.5 (14.8) 98.7 (12.0) 95.7 (14.4) 103.6 (12.9) ni 
BMI ≥30 kg/m2, No. (%) 558 (27.3) 597 (33.8) 1499 (36.9) 982 (29.4) 655 (34.9) 611 (33.2) 3218 (19.9) 
Smoking, No. (%)         
  Never 1055 (51.6) 944 (53.5) 2331 (57.4) 1356 (40.6) 1070 (57.0) 714 (38.8) 8164 (50.5) 
  Former 846 (41.3) 713 (40.4) 1316 (32.4) 1646 (49.3) 503 (26.8) 712 (38.7) 7461 (46.1) 
  Current 145 (7.1) 108 (6.1) 418 (10.3) 341 (10.2) 304 (16.2) 414 (22.5) 550 (3.4) 
Ethnicity, No. (%)*        
  White 1844 (90.1) 1610 (91.2) 2614 (64.4) 2475 (74.1) 1455 (77.5) 1456 (79.1) 15418 (95.3) 
  Black 65 (3.2) 40 (2.3) 1447 (35.6) 864 (25.9) 182 (9.7) 160 (8.7) 246 (1.5) 
  Other 137 (6.7) 115 (6.5) 0 (0.0) 0 (0.0) 241 (12.8) 224 (12.2) 511 (3.2) 
Prevalent CVD, No. (%) 133 (5.5) 182 (10.3) 345 (8.5) 564 (16.9) 188 (10.0) 234 (12.7) 379 (2.3) 
Prevalent Cancer, No. (%) 332 (16.2) 251 (14.2) ni ni 248 (13.2) 184 (10.0) 1886 (11.7) 
LPA; light intensity physical activity, MVPA; moderate-to-vigorous physical activity, BMI; body mass index, CVD; cardiovascular disease, Ni: no information, REGARDS; REasons for Geographical 
and Racial differences in Stroke, ABC; Sweden Attitude, Behaviour and Change study, BRHS; British Regional Heart Study, WHS; Women’s Health Study, FHS; Framingham Heart Study, 
NHANES; National Health and Nutrition Examination Study, NNPAS; Norwegian National Physical Activity Survey, EPIC-Norfolk; The European Prospective Investigation into Cancer and Nutrition – 
Norfolk. All studies used a version of the Actigraph accelerometers, except REGARDS and FHS which used Actical accelerometers. *Numbers may not sum to total sample due to missing data.  
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